The $164B Supplement Market: Where the Growth Is Now

The global vitamins and supplements market is valued at $164.4 billion in 2025 and is on a trajectory toward $284 billion by 2034, according to a May 2026 market report. That's a compound annual growth rate that outpaces most consumer health categories. But if you're a brand operator looking to capture outsized returns, tracking the aggregate number is the wrong frame. The real question is which sub-segments are compounding faster than the market average, and whether your positioning puts you inside or outside that growth curve.

This isn't a rising-tide story. It's a story about structural shifts in consumer behavior, regulatory pressure in key markets, and institutional capital making very deliberate bets on specific formats. Each of those forces is reshaping the competitive landscape in ways that reward brands with clarity of focus and punish those coasting on category momentum.

M&A Is Telling You Exactly Where the Value Is

When three major food and beverage conglomerates each pay nine-figure or ten-figure sums for supplement and nutrition brands within the same 12-month window, that's not coincidence. It's a consensus view from institutional capital about where durable margin lives.

Unilever paid $1.2 billion for Grüns, a gummy supplement brand that had built a loyal direct-to-consumer base around complete daily nutrition. Lactalis acquired Protein Works, a UK-based performance nutrition brand with strong online distribution. Danone acquired meal replacement and complete nutrition brand Huel for approximately $1.1 billion. Three deals, three acquirers, one common theme: complete nutrition and functional formats, delivered in convenient, repeatable formats that build subscription-like purchase behavior.

For brand operators, the signal here isn't just about exit multiples. It's about what these acquirers are actually buying. They're paying premiums for habit-embedded consumption, clean ingredient positioning, and formats that travel across demographics without heavy category education. If your product requires a PhD to explain at shelf, you're competing in the wrong tier of this market. For a deeper breakdown of the Grüns deal and its implications, Unilever Buys Grüns for $1.2B: What It Signals for Supplements is worth reading in full.

The Sub-Segments Driving Above-Average Growth

Not every category inside the $164 billion market is growing at the same rate. Several sub-segments are outpacing the broader CAGR by a meaningful margin, and they share identifiable characteristics.

Complete nutrition and meal replacement formats. The Huel and Grüns acquisitions both point to this. Consumers are collapsing the gap between supplements and food, looking for products that simplify their nutritional baseline rather than adding complexity. Brands that occupy this "nutritional foundation" position have higher purchase frequency and lower churn.
Condition-specific functional supplements. Categories tied to sleep, cognitive performance, metabolic health, and hormonal support are growing faster than general multivitamins. This is partly demographic, driven by aging populations in the US, UK, and Australia, and partly driven by a more sophisticated consumer who is self-diagnosing and actively seeking targeted solutions.
Sports and performance nutrition. Protein-led categories continue to expand beyond the gym demographic. Protein Works' acquisition by Lactalis underscores that performance nutrition is now a mainstream food category, not a niche one. The addressable market is no longer "gym users." It's anyone managing body composition, energy, or recovery as a daily priority.
Gummy and functional food formats. Format innovation is compressing the barrier between supplement-taking and everyday consumption. Gummies and functional snacks remove the clinical friction of capsules and powders, which directly expands the addressable demographic to older consumers and less engaged health audiences.

The brands capturing the most growth in each of these sub-segments share one structural trait: they've made it easy to be a consistent customer. Subscription models, condition-specific bundling, and personalized formulations all serve the same goal: reducing the cognitive load of the purchase decision so repeat behavior becomes default.

EU Regulatory Risk: The Reformulation Window Most Brands Are Missing

The European Union introduced updated vitamin and mineral cap regulations in 2026, establishing new upper limits on dosage levels across a range of nutrients. For brands with European distribution, this is a direct reformulation trigger. Products that were compliant last year may now exceed permitted levels for vitamins D, B6, folic acid, and several minerals.

The brands that have priced this into their product development roadmaps are already working through reformulation timelines, updated label approvals, and distribution partner communications. The brands that haven't are accumulating a compliance liability that will surface at the worst possible time, typically during a growth phase or a fundraising process when due diligence scrutiny is highest.

This is a structural advantage for well-resourced brands. Larger operators with dedicated regulatory affairs teams can absorb reformulation cycles without disrupting market availability. Smaller brands with lean teams and tight cash cycles often can't. The result is predictable: shelf space and distribution relationships shift toward the brands that maintained continuity. If you're operating at scale and your EU reformulation plan is already locked, you're positioned to capture the distribution gaps that smaller competitors will leave behind.

The regulatory environment in Europe also creates a ceiling effect on certain high-dose, aggressive-positioning brands that have built audiences around maximum-dosage claims. As those products face compliance pressure, their customers don't disappear. They migrate to the next best available option. That migration is an acquisition opportunity for brands with compliant, well-formulated alternatives ready in market.

Vertical Integration Is Now a Strategic Asset, Not a Cost Play

Applied Nutrition's $16 million acquisition of Nutrablend Group assets, including a Buffalo, New York production facility and two in-house brands, is a case study in how the competitive logic of supplement manufacturing has shifted. This wasn't a cost-reduction move. It was a strategic positioning decision about control.

When you own your manufacturing capacity, you control your lead times, your minimum order quantities, your formulation iteration speed, and your margin structure. In a market where new product launches need to respond to trend cycles measured in months, not years, that control is worth more than the capital efficiency of outsourcing to a co-manufacturer.

The broader trend here is that contract manufacturing, while still the right model for early-stage brands, becomes a ceiling at a certain revenue threshold. When you're moving enough volume that a co-manufacturer's capacity constraints are dictating your launch calendar, you've outgrown the model. Applied Nutrition's Nutrablend acquisition signals that for brands targeting serious North American scale, vertical integration is now a competitive differentiator that belongs in the strategic roadmap, not just the finance spreadsheet.

It also changes the M&A calculus. An acquirer paying a premium multiple for a supplement brand is also paying for the predictability of that brand's supply chain. Proprietary manufacturing facilities reduce the due diligence risk around third-party dependencies, which directly supports higher valuation multiples at exit. If you're building toward an institutional outcome, owned manufacturing is a balance sheet asset that tells a cleaner story.

What This Means for Your Brand Positioning Right Now

The $164 billion market size is a headline. What matters for your brand is whether you're positioned inside the sub-segments that are growing at two or three times the market average, or whether you're competing in the commoditized center of the market where price pressure is relentless and differentiation is hard to sustain.

Here's where the practical implications land for operators:

Audit your format strategy. If your entire product line is capsules and powders, you're limiting your addressable demographic. Format diversification into gummies, functional foods, or ready-to-drink options isn't a brand extension exercise. It's a customer acquisition strategy for demographics that won't engage with traditional supplement formats.
Build your EU regulatory posture now. If you have any European distribution or plan to enter European markets in the next 24 months, the 2026 vitamin cap regulations need to be in your product development brief today. Catching up after the fact is expensive and operationally disruptive.
Evaluate your manufacturing dependency. You don't need to acquire a facility at $16 million to think strategically about supply chain control. But you should know at what revenue level your current co-manufacturing arrangement becomes a constraint, and what your transition plan looks like.
Position in the complete nutrition space if your brand architecture allows it. The M&A premiums are clustering here. Consumer behavior supports it. And the competitive dynamics favor brands that can own a broader daily nutrition role rather than a single SKU occasion.

The supplement market's growth toward $284 billion isn't guaranteed to benefit every brand operating in the space. The brands that will capture disproportionate returns are the ones treating the next decade as a positioning decision, not a distribution exercise. The capital is moving. The question is whether your brand is in the path of it.